title: Ammonium increases Ca(2+) signalling and up-regulates expression of TRPC1 gene in astrocytes in primary cultures and in the in vivo brain.
abstract: Rapid rise in ammonium concentration in the brain is the major pathogenic factor in hepatic encephalopathy that is manifested by state of confusion, forgetfulness and irritability, psychotic symptoms, delusions, lethargy, somnolence and, in the terminal stages, coma. Primary cultures of mouse astrocytes were used to investigate effects of chronic treatment (3 days) with ammonium chloride (ammonium) at 3 mM, this being a relevant concentration for hepatic encephalopathy condition, on metabotropic receptor agonist-induced increases in free cytosolic Ca(2+) concentration [(Ca(2+))i], measured with fura-2 based microfluorimetry and on store-operated Ca(2+) entry (SOCE) activated following treatment with the SERCA inhibitor thapsigargin. The agonists used were the β-adrenergic agonist isoproterenol, the α2-adrenergic agonist dexmedetomidine, the InsP3 receptor (InsP3R) agonist adenophostin A and ryanodine receptor agonist 4-Chloro-m-cresol (4-CMC). Agonist-induced [Ca(2+)]i responses were significantly increased in astrocytes chronically exposed to ammonium. Similarly, the SOCE, meditated by the transient receptor potential channel 1 (TRPC1), was significantly augmented. The ammonium-induced increase in SOCE was a result of an up-regulation of mRNA and protein expression of TRPC1 in astrocytes. Increase in TRPC1 expression and in SOCE were both prevented by ouabain antagonist canrenone. Similar up-regulation of TRPC1 gene expression was found in the brain of adult mice subjected to intraperitoneal injection of urease for 3 days. In transgenic mice tagged with an astrocyte-specific or a neurone-specific markers and treated with intraperitoneal injections of urease for 3 days, the fluorescence-activated cell sorting of neurones and astrocytes demonstrated that TRPC1 mRNA expression was up-regulated in astrocytes, but not in neurones.
authors.affiliation: Laboratory of Metabolic Brain Diseases, Institute of Metabolic Disease Research and Drug Development, China Medical University, No. 92 Beier Road, Heping District, Shenyang, People's Republic of China.
authors.forename: Chunguang
authors.initials: C
authors.lastname: Liang
authors.forename: Ting
authors.initials: T
authors.lastname: Du
authors.forename: Jing
authors.initials: J
authors.lastname: Zhou
authors.forename: Alexei
authors.initials: A
authors.lastname: Verkhratsky
authors.forename: Liang
authors.initials: L
authors.lastname: Peng
mesh_terms: D064751:Ammonium Compounds / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D001253:Astrocytes / Q000187:drug effects* / Q000378:metabolism; D001921:Brain / Q000378:metabolism*; D002118:Calcium / Q000378:metabolism*; D020013:Calcium Signaling; D002478:Cells, Cultured; D005260:Female; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D050052:TRPC Cation Channels / Q000235:genetics*; D015854:Up-Regulation / Q000187:drug effects
chemical_list: D064751:Ammonium Compounds; D050052:TRPC Cation Channels; C096351:transient receptor potential cation channel, subfamily C, member 1; D002118:Calcium
references.citation: Neurochem Int. 2010 Nov;57(4):383-8
references.pmid: 20350577
references.citation: Rev Physiol Biochem Pharmacol. 2014;166:1-22
references.pmid: 23784619
references.citation: Sci Signal. 2012 Apr 03;5(218):ra26
references.pmid: 22472648
references.citation: Nature. 2006 May 11;441(7090):179-85
references.pmid: 16582901
references.citation: Neurochem Res. 1978 Feb;3(1):1-14
references.pmid: 683409
references.citation: J Neuropathol Exp Neurol. 1993 May;52(3):205-15
references.pmid: 8388039
references.citation: Trends Neurosci. 2012 Aug;35(8):497-506
references.pmid: 22633141
references.citation: Semin Liver Dis. 1986 May;6(2):107-18
references.pmid: 3018935
references.citation: Clin Sci Mol Med. 1975 Jan;48(1):33-7
references.pmid: 234316
references.citation: Virchows Arch B Cell Pathol Incl Mol Pathol. 1984;46(3):187-97
references.pmid: 6148800
references.citation: Biochim Biophys Acta. 2009 Feb;1793(2):223-30
references.pmid: 19061922
references.citation: J Neurochem. 2010 Nov;115(4):1007-23
references.pmid: 20831657
references.citation: J Biol Chem. 2003 Oct 3;278(40):39014-9
references.pmid: 12857742
references.citation: Microbiol Rev. 1989 Mar;53(1):85-108
references.pmid: 2651866
references.citation: Acta Neurol Scand. 1977 Jun;55(6):425-42
references.pmid: 878834
references.citation: Glia. 2008 Jun;56(8):821-35
references.pmid: 18338793
references.citation: Cell Calcium. 2013 Nov;54(5):335-42
references.pmid: 24079970
references.citation: Mol Biol Cell. 2006 Jan;17(1):317-26
references.pmid: 16267270
references.citation: Cell Calcium. 2005 Sep-Oct;38(3-4):303-10
references.pmid: 16076486
references.citation: Steroids. 1995 Jan;60(1):110-3
references.pmid: 7792794
references.citation: Biochim Biophys Acta. 2011 May;1813(5):984-91
references.pmid: 21118669
references.citation: Dtsch Med Wochenschr. 2012 Sep;137(38):1853-6
references.pmid: 22971971
references.citation: Acta Vet Scand Suppl. 1989;85:29-37
references.pmid: 2571275
references.citation: Carcinogenesis. 2000 Dec;21(12):2211-8
references.pmid: 11133810
references.citation: Brain Res. 2003 Jul 18;978(1-2):65-71
references.pmid: 12834899
references.citation: J Biol Chem. 2005 Jun 3;280(22):20937-44
references.pmid: 15802262
references.citation: J Physiol. 2005 May 1;564(Pt 3):737-49
references.pmid: 15731184
references.citation: Mol Cell Endocrinol. 2012 Apr 28;353(1-2):45-56
references.pmid: 21945602
references.citation: J Neurosci Res. 1989 Feb;22(2):209-15
references.pmid: 2709443
references.citation: Physiol Rev. 1997 Oct;77(4):901-30
references.pmid: 9354808
references.citation: Liver Int. 2009 Jul;29(6):783-8
references.pmid: 19638106
references.citation: Cell Calcium. 2007 Aug;42(2):103-10
references.pmid: 17349691
references.citation: Neurochem Res. 2002 Feb;27(1-2):113-20
references.pmid: 11930908
references.citation: Pediatr Res. 1986 Dec;20(12):1310-5
references.pmid: 3797124
references.citation: Biochem Soc Trans. 2013 Dec;41(6):1518-24
references.pmid: 24256247
references.citation: Neurochem Int. 2012 Jul;61(2):187-94
references.pmid: 22564531
references.citation: Transl Neurosci. 2012 Dec;3(4):334-344
references.pmid: 23243501
references.citation: J Neurosci. 2007 Nov 7;27(45):12255-66
references.pmid: 17989291
references.citation: Neurochem Int. 2010 Nov;57(4):395-403
references.pmid: 20447429
references.citation: Cell Calcium. 2011 Jul;50(1):42-53
references.pmid: 21640379
references.citation: Methods. 1998 Nov;16(3):293-310
references.pmid: 10071068
references.citation: Nat Rev Neurosci. 2013 Dec;14(12):851-8
references.pmid: 24149188
references.citation: Neurotherapeutics. 2010 Oct;7(4):452-70
references.pmid: 20880508
references.citation: Neurochem Int. 2013 Nov;63(6):610-25
references.pmid: 24044899
references.citation: Neurosci Bull. 2014 Feb;30(1):125-33
references.pmid: 23677809
references.citation: Cell Calcium. 2013 Aug;54(2):120-5
references.pmid: 23764169
references.citation: Neurosci Lett. 2002 Aug 30;329(2):185-8
references.pmid: 12165408
references.citation: Ann N Y Acad Sci. 1975 Apr 25;252:116-23
references.pmid: 238449
references.citation: Cell Calcium. 1990 Nov-Dec;11(10):611-24
references.pmid: 1965707
references.citation: Neuron. 2000 Oct;28(1):41-51
references.pmid: 11086982
references.citation: J Physiol. 2009 Jun 1;587(Pt 11):2429-42
references.pmid: 19332490
references.citation: J Biol Chem. 1951 Nov;193(1):265-75
references.pmid: 14907713